Mar 10, 2017 12:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., March 10, 2017 -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor...
Roper Technologies Announces Senior Executive Appointments
Mar 10, 2017 11:55 am UTC| Business
Robert Crisci Named Vice President and Chief Financial Officer Jason Conley Named Vice President and Controller Neil Hunn and Paul Soni Named Executive Vice Presidents SARASOTA, Fla., March 10, 2017 -- Roper...
Superior Drilling Products, Inc. Achieves $2.3 million in Revenue for Fourth Quarter 2016
Mar 10, 2017 11:30 am UTC| Business
VERNAL, Utah, March 10, 2017 -- Superior Drilling Products, Inc. (NYSE MKT:SDPI) (“SDP” or the “Company”), a designer and manufacturer of drilling tool technologies, today reported financial results for the fourth...
Diversified Restaurant Holdings Reports Fourth Quarter and Fiscal Year 2016 Results
Mar 10, 2017 11:30 am UTC| Business
Operating profit in 2016 increases 2.6 times andoperating margin more than doubles on higher revenue and lower costs SOUTHFIELD, Mich., March 10, 2017 -- Diversified Restaurant Holdings, Inc. (NASDAQ:SAUC) ("DRH" or...
ChromaDex to Report Year End 2016 Financial Results on Thursday, March 16, 2017
Mar 10, 2017 11:30 am UTC| Business
IRVINE, Calif., March 10, 2017 -- ChromaDex Corp. (NASDAQ:CDXC), an innovator of proprietary health, wellness and nutritional ingredients, that creates science-based solutions for dietary supplement, food and beverage,...
Vical to Provide Company Update at the 29th Annual ROTH Conference
Mar 10, 2017 11:30 am UTC| Business
SAN DIEGO, March 10, 2017 -- Vical Incorporated (Nasdaq:VICL) today announced that the company will provide an overview of its technologies, development programs, and outlook at 12:30 p.m. PT on Wednesday, March 15, at...
Mar 10, 2017 11:00 am UTC| Business
PALO ALTO, Calif. and RESEARCH TRIANGLE PARK, N.C., March 10, 2017 -- Ocera Therapeutics, Inc. (NASDAQ:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today...